Research and Evaluation Division, Society for Family Health, Abuja, Nigeria.
Planning, Research and Statistics Directorate, National Agency for Food and Drug Administration and Control, Abuja, Nigeria.
J Multidiscip Healthc. 2014 Apr 8;7:163-71. doi: 10.2147/JMDH.S57117. eCollection 2014.
In Nigeria about 50% of oral contraceptive pill users obtain their products from proprietary patent medicine vendors (PPMVs). This group of service providers are poorly trained and have very limited knowledge about contraception. This paper investigated the nature of the advice offered to simulated current and potential users of oral contraceptive pills. The main objective was to assess the nature and quality of advice provided by PPMVs to pill users.
This study is based on findings from a 'mystery client' approach in which three scenarios related to contraceptive pill use were simulated. Each of the 12 mystery clients simulated one of the following three scenarios: new pill users (new to family planning or switching from condom to pills); user seeking a resupply of pills; and dissatisfied pill users intending to discontinue use. Simple random sampling was used to select 410 PPMVs from a total of 1,826 in four states in Nigeria. Qualitative study using in-depth interviews was also conducted.
A majority of the PPMVs had pills in stock on the day of the survey and resupplied pills to the clients. PPMVs also understood the reason and importance of referring clients who were new adopters of oral contraceptive methods to a health facility; 30% of the PPMVs referred new adopters to a health facility. However, demand from clients who do not want to go to health care facilities (for various reasons) necessitated the provision of oral contraceptive pills to 41% of the first time users. Some PPMVs prescribed treatment to mystery clients who presented with perceived complications arising from the use of pills, while 49% were referred to a health facility.
The advice given by PPMVs often falls short of safety guidelines related to the use of oral contraceptive pills. There is a need to continuously update knowledge among the PPMVs to ensure that they provide quality oral contraceptive services as PPMVs bridge the gap between medical experts and users in rural communities.
在尼日利亚,约有 50%的口服避孕药使用者从专利药品供应商(PPMVs)处购买其产品。这一类服务提供者接受的培训很差,对避孕的了解非常有限。本文调查了向模拟的当前和潜在口服避孕药使用者提供的咨询的性质。主要目的是评估 PPMV 向避孕药使用者提供的咨询的性质和质量。
本研究基于“神秘客户”方法的调查结果,其中模拟了与避孕药使用相关的三个情景。每个神秘客户模拟以下三种情景之一:新的避孕药使用者(新的计划生育使用者或从避孕套转为避孕药使用者);使用者要求补充避孕药;以及不满避孕药使用者打算停止使用。简单随机抽样从尼日利亚四个州的总共 1826 个专利药品供应商中选择了 410 个专利药品供应商。还进行了基于定性访谈的深入研究。
大多数专利药品供应商在调查当天有库存药品,并向客户供应药品。专利药品供应商也理解将新采用口服避孕方法的客户转介到医疗机构的原因和重要性;30%的专利药品供应商将新采用者转介到医疗机构。然而,由于各种原因,不愿去医疗机构的客户的需求使得 41%的首次使用者获得了口服避孕药。一些专利药品供应商向出现服用避孕药后出现的认为的并发症的神秘客户提供了治疗,而 49%的客户被转介到医疗机构。
专利药品供应商提供的建议往往不符合与口服避孕药使用相关的安全指南。需要不断更新专利药品供应商的知识,以确保他们提供高质量的口服避孕药服务,因为专利药品供应商在医疗专家和农村社区用户之间架起了桥梁。